BIVISTA: multi-modality imaging for improving surgical intervention

胰腺癌和乳腺癌等主要癌症（全球发病率分别超过277，000和1，383，000）依赖于手术干预。面临的挑战是通过介入成像技术降低这些和其他类型癌症的死亡率，这些技术可以在手术时帮助临床医生和外科医生。临床诊断形成了改善患者管理的基础，我们建议，在护理点的高质量成像将有助于更好的诊断和治疗结果为patient.Gamma相机常规使用在许多领域的医学成像不同的组织类型和过程中使用放射性“示踪剂”化合物注射到病人。由此产生的图像是非常有价值的临床医生在分期和治疗的各种条件。BIVISTA系统固有的多光谱成像组合将改善各种癌症和其他疾病的诊断和治疗管理。已就BIVISTA概念提出专利申请。BIVISTA与大视场伽马相机相比的优势包括：独特地结合了伽马和光学成像分辨率更高，可以对较小区域的组织成像或研究其他过程，如淋巴引流紧凑型和移动终端提供真实的时间成像，可用于各种环境，例如床边和手术室。多模态成像：同步光学和伽马射线以及绘制荧光标记的能力;手术实践中的新兴技术。 患者体内活动的3D分布的高空间分辨率信息BIVISTA将为一系列患者提供显著的医疗保健益处。

Major cancers such as pancreatic and breast cancer (worldwide incidence of over 277,000 and 1,383,000 respectively) rely on surgical intervention. The challenge is to reduce the mortality rate for these and other types of cancer through interventional imaging techniques that can assist clinicians and surgeons at the time of operation. Clinical diagnosis forms the basis for improved patient management and we propose that high quality imaging at the point of care will contribute to better diagnosis and treatment outcomes for patients.Gamma cameras are used routinely in many areas of medicine to image different tissue types and processes using radioactive 'tracer' compounds injected into the patient. The resulting images are of great value to the clinician in the staging and treatment of a variety of conditions. The combination of multi-spectral imaging, inherent in the BIVISTA system, will improve diagnosis and hence treatment management in a wide variety of cancers and other diseases. A patent application has been filed on the BIVISTA concept. The advantages of the BIVISTA versus larger-field gamma cameras include: Uniquely combines gamma and optical imaging Much higher resolution which allows imaging of smaller areas of tissue or the study of other processes such as lymph drainage Compact and mobile device offering real time imaging that can be used in a variety of environments, for example at the bedside and in the operating theatre. Multi-modality imaging: simultaneous optical and gamma ray and the ability to map fluorescence markers; an emerging technology in surgical practice. High spatial resolution information of 3D distribution of activity within the patientBIVISTA will deliver significant healthcare benefits to a range of patients.